Cargando…

Facile repurposing of peptide–MHC-restricted antibodies for cancer immunotherapy

Monoclonal antibodies (Abs) that recognize major histocompatability complex (MHC)-presented tumor antigens in a manner similar to T cell receptors (TCRs) have great potential as cancer immunotherapeutics. However, isolation of ‘TCR-mimic’ (TCRm) Abs is laborious because Abs have not evolved the stru...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Xinbo, Nishimiya, Daisuke, Löchte, Sara, Jude, Kevin M., Borowska, Marta, Savvides, Christina S., Dougan, Michael, Su, Leon, Zhao, Xiang, Piehler, Jacob, Garcia, K. Christopher
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group US 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344781/ https://www.ncbi.nlm.nih.gov/pubmed/36593402 http://dx.doi.org/10.1038/s41587-022-01567-w

Ejemplares similares

Restricted MHC–peptide repertoire predisposes to autoimmunity
por: Logunova, Nadezda N., et al.
Publicado: (2005)

Live cell micropatterning reveals the dynamics of signaling complexes at the plasma membrane
por: Löchte, Sara, et al.
Publicado: (2014)

Identical peptides recognized by MHC class I- and II-restricted T cells
Publicado: (1989)

Design of Peptide Immunotherapies for MHC Class-II-Associated Autoimmune Disorders
por: Fridkis-Hareli, Masha
Publicado: (2013)

The impact of DM on MHC class II–restricted antigen presentation can be altered by manipulation of MHC–peptide kinetic stability
por: Lazarski, Christopher A., et al.
Publicado: (2006)

Atheroprotective Vaccination with MHC-II Restricted Peptides from ApoB-100
por: Tse, Kevin, et al.
Publicado: (2013)

Enhanced presentation of MHC class Ia, Ib and class II-restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapy
por: Ma, Wenxue, et al.
Publicado: (2011)

Antibody-mediated delivery of a viral MHC-I epitope into the cytosol of target tumor cells repurposes virus-specific CD8(+) T cells for cancer immunotherapy
por: Jung, Keunok, et al.
Publicado: (2022)

Rules of engagement: the discovery of MHC restriction
Publicado: (2005)

MHC Restriction: Where Are We Now?
por: Zareie, Pirooz, et al.
Publicado: (2020)

Epitopes associated with MHC restriction site of T cells. III. I-J epitope on MHC-restricted T helper cells
Publicado: (1987)

Apparent lack of MHC restriction in binding of class I HLA molecules to solid-phase peptides
Publicado: (1990)

Unbiased Identification of T-Cell Receptors Targeting Immunodominant Peptide–MHC Complexes for T-Cell Receptor Immunotherapy
por: Lorenz, Felix K.M., et al.
Publicado: (2017)

Thermostability profiling of MHC-bound peptides: a new dimension in immunopeptidomics and aid for immunotherapy design
por: Jappe, Emma C., et al.
Publicado: (2020)

Thymus dictates major histocompatibility complex (MHC) specificity and immune response gene phenotype of class II MHC-restricted T cells but not of class I MHC-restricted T cells
Publicado: (1984)

MHC-independent αβT cells: Lessons learned about thymic selection and MHC-restriction
por: Van Laethem, François, et al.
Publicado: (2022)

The Conventional Nature of Non-MHC-Restricted T Cells
por: Lepore, Marco, et al.
Publicado: (2018)

The Macroautophagy Machinery in MHC Restricted Antigen Presentation
por: Münz, Christian
Publicado: (2021)

Coreceptor affinity for MHC defines peptide specificity requirements for TCR interaction with coagonist peptide–MHC
por: Hoerter, John A.H., et al.
Publicado: (2013)

The V beta complementarity determining region 1 of a major histocompatibility complex (MHC) class I-restricted T cell receptor is involved in the recognition of peptide/MHC I and superantigen/MHC II complex
Publicado: (1994)

Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy
por: Reits, Eric A., et al.
Publicado: (2006)

One-Pot, Mix-and-Read Peptide-MHC Tetramers
por: Leisner, Christian, et al.
Publicado: (2008)

Repurposing infectious disease vaccines for intratumoral immunotherapy
por: Melero, Ignacio, et al.
Publicado: (2020)

Repurposing the yellow fever vaccine for intratumoral immunotherapy
por: Aznar, Maria Angela, et al.
Publicado: (2019)

Peptide-MHC heterodimers show that thymic positive selection requires a more restricted set of self-peptides than negative selection
por: Juang, Jeremy, et al.
Publicado: (2010)

A strategy for the selection of monovalent antibodies that span protein dimer interfaces
por: Spangler, Jamie B., et al.
Publicado: (2019)

MetaMHC: a meta approach to predict peptides binding to MHC molecules
por: Hu, Xihao, et al.
Publicado: (2010)

Linkage of Bacterial Protein Synthesis and Presentation of MHC Class I-Restricted Listeria monocytogenes-Derived Antigenic Peptides
por: Grauling-Halama, Silke, et al.
Publicado: (2012)

Neoleukin-2 enhances anti-tumour immunity downstream of peptide vaccination targeted by an anti-MHC class II VHH
por: Crowley, Stephanie J., et al.
Publicado: (2020)

Metformin Suppresses MHC-Restricted Antigen Presentation by Inhibiting Co-Stimulatory Factors and MHC Molecules in APCs
por: Shin, Seulmee, et al.
Publicado: (2013)

Exosomal cancer immunotherapy is independent of MHC molecules on exosomes
por: Hiltbrunner, Stefanie, et al.
Publicado: (2016)

Mechanisms of MHC-I Downregulation and Role in Immunotherapy Response
por: Taylor, Brandie C., et al.
Publicado: (2022)

MHC Class II Restricted Innate-Like Double Negative T Cells Contribute to Optimal Primary and Secondary Immunity to Leishmania major
por: Mou, Zhirong, et al.
Publicado: (2014)

Immunization with SV40-transformed cells yields mainly MHC-restricted monoclonal antibodies
Publicado: (1986)

Design of a predicted MHC restricted short peptide immunodiagnostic and vaccine candidate for Fowl adenovirus C in chicken infection
por: Valdivia-Olarte, Hugo, et al.
Publicado: (2015)

Drug Repurposing at the Interface of Melanoma Immunotherapy and Autoimmune Disease
por: Spitschak, Alf, et al.
Publicado: (2022)

Repurposable Drugs for Immunotherapy and Strategies to Find Candidate Drugs
por: Sakai, Norihiro, et al.
Publicado: (2023)

Molecular basis of MHC I quality control in the peptide loading complex
por: Domnick, Alexander, et al.
Publicado: (2022)

Cordyceps militaris Enhances MHC-restricted Antigen Presentation via the Induced Expression of MHC Molecules and Production of Cytokines
por: Shin, Seulmee, et al.
Publicado: (2010)

Classical MHC expression by DP thymocytes impairs the selection of non-classical MHC restricted innate-like T cells
por: Georgiev, Hristo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_revv73lj4440vgcb7purith8ul